Treatable Traits in Chronic Rhinosinusitis
09-11, 07:00– (Europe/Istanbul), Rhinology 2 ( ICC - B2 level MACKA)

Treatable Traits in Chronic Rhinosinusitis

Dr. Jonathan Yip is a Clinical Assistant Professor in the Section of Otolaryngology – Head & Neck Surgery at the University of Calgary, and is a Rhinologist based out of Rockyview General Hospital. He completed his medical degree and residency training at the University of Toronto before pursuing an advanced fellowship in Rhinology and Endoscopic Skull Base Surgery at Northwestern University (Chicago, IL, USA) under the mentorship of Drs. David Conley, Robert Kern, Kevin Welch and Bruce Tan. After fellowship, he returned to Toronto for three years before being recruited to the University of Calgary in 2022.

Dr. Yip’s clinical focus is on recalcitrant chronic rhinosinusitis, sinonasal tumours, and endoscopic skull base surgery (in collaboration with neurosurgery). His research interests include the development of quality metrics/indicators, as well as quality improvement and patient safety. He also serves as the Quality Improvement and Safety Lead for the Section Otolaryngology – Head and Neck Surgery. Dr. Yip is currently pursuing a Master’s Degree in Healthcare Quality at Queen’s University.

In addition, Dr. Yip is active in teaching undergraduate and post-graduate trainees. He currently serves on the Residency Training and Competence Committees for Postgraduate Education. As a trainee, he was voted by his co-residents as the “Resident Teacher of the Year” (2018). More recently, he was acknowledged as the “Faculty Teacher of the Year” in the Section of Otolaryngology – Head & Neck Surgery at the University of Calgary (2023).

Dr. Leigh J. Sowerby, MD, MHM, FRCSC is an academic otolaryngologist and the Division Chief of Rhinology and Anterior Skull Base Surgery at Western University’s Schulich School of Medicine & Dentistry. He is an Associate Professor with cross-appointments in Otolaryngology, Clinical Neurological Sciences, Medicine (Allergy), and Ophthalmology. A graduate of the University of Calgary (MD) and the University of Western Ontario (FRCSC), Dr. Sowerby completed advanced fellowship training in Rhinology and Skull Base Surgery at the University of Alberta and holds a Master’s in Health Management from McMaster University.

Dr. Sowerby is a leading Canadian expert in chronic rhinosinusitis, nasal obstruction, septorhinoplasty, olfaction, and anterior skull base surgery. He has served as principal or co-investigator on more than 10 phase III clinical trials and multiple federally funded research initiatives including CIHR, NIH, and CFI grants. His work focuses on therapeutic innovations, surgical outcomes, health economics, and care optimization. He has authored or co-authored over 100 peer-reviewed publications. In addition to his clinical and academic roles, he is a recognized innovator in surgical efficiency and outpatient care redesign, committed to advancing evidence-based, patient-centered otolaryngology care in Canada and internationally.

Dr. Sowerby is also known for his leadership in anosmia and parosmia awareness, frequently contributing to national media and patient advocacy initiatives during and after the COVID-19 pandemic. An active educator, he is a past recipient of multiple teaching awards and has led medical outreach and training programs in Guyana.

This speaker also appears in:

Dr Christopher J Chin attended medical school and residency in London, Ontario at Western University. He subsequently completed his fellowship in Rhinology, Anterior Skull Base Surgery, and Head and Neck Oncology at the University of Toronto. He is the former Division Head of Otolaryngology-Head and Neck Surgery at the Saint John Regional Hospital. He is an Assistant Professor in the Division of Otolaryngology-Head and Neck Surgery at Dalhousie University.

After completing his fellowship in rhinology and anterior skull base surgery in Toronto, he helped launch the New Brunswick Neuropituitary clinic as well as the Multidisciplinary Airway Clinic for treatment of complex sinus disease in Saint John. He has since relocated to Halifax where he serves as the Residency Program Director for Otolaryngology as of April 2025.  Dr Chin has published over 45 peer-reviewed papers, 3 textbook chapters and is former chair of the Rhinology subgroup of the Canadian Society of Otolaryngology.

This speaker also appears in: